MedWatch: June 2011 Safety Labeling Changes: 50 products with changes to Boxed Warning, Warnings, Contraindications, Precautions, Adverse Reactions

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: MedWatch: June 2011 Safety Labeling Changes: 50 products with changes to Boxed Warning, Warnings, Contraindications, Precautions, Adverse Reactions

The MedWatch June 2011 Safety Labeling Changes posting includes 50 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.

 

The "Summary Page" provides a listing of drug names and safety labeling sections revised:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm261325.htm

 

Clicking on a drug product name in the Summary View will take you to the "detailed view" page, which identifies safety labeling sections and subsections revised, along with a brief summary of new or modified safety information.

 

The following drugs had modifications to the BOXED WARNINGS, CONTRAINDICATIONS and WARNINGS sections:    

 

Avalide (irbesartan/hydrochlorothiazide) tablets

Avodart (dutasteride) soft gelatin capsules    

Corgard (nadolol) tablets    

Corzide (nadolol and bendroflumethiazide) tablets  

Diflucan (fluconazole) tablets, I.V, and oral suspension      

Diovan (valsartan) tablets

Ditropan XL (oxybutynin chloride) tablets  

Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets

Feraheme (ferumoxytol) injection

Fioricet with Codeine (butalbital, acetaminophen, caffeine, and codeine phosphate) Capsules

Jalyn (dutasteride and tamsulosin) capsules  

Kenalog-10 (triamcinolone acetonide) injection and Kenalog-40 (triamcinolone acetonide) injection  

Nexium (esomeprazole magnesium) for delayed-release oral suspension, delayed-release capsules and (esomeprazole sodium) for injection    

Photofrin (porfimer sodium) for injection

Prilosec (omeprazole magnesium) for delayed-release oral suspension and delayed-release capsules

Proscar (finasteride) tablets    

Prozac Pulvules (fluoxetine hydrochloride) capsules for oral use and Prozac Weekly (fluoxetine hydrochloride) delayed-release capsules

Renagel (sevelamer hydrochloride) tablets and Renvela (sevelamer carbonate) powder for oral suspension and tablets      

Simcor (niacin extended-release/simvastatin) tablets  

Sumavel DosePro (sumatriptan) injection for subcutaneous use

Talacen (pentazocine hydrochloride and acetaminophen) tablets

Tekturna HCT (aliskiren/hydrochlorothiazide) tablets

Torisel (temsirolimus) injection        

Ultracet (tramadol HCl/acetaminophen) tablets

Venofer (iron sucrose) injection

Vimovo (naproxen/esomeprazole magnesium) tablets

Vytorin (ezetimibe/simvastatin) tablets

Zmax (azithromycin extended release) for oral suspension  

Zocor (simvastatin) tablets  

 Tell us what you think:  http://survey.foreseeresults.com/survey/display?cid=d509U9xg0gZVxkMRcoMsQg==&sid=link&cpp[date]=7-14-2011 1300&cpp[type]=info


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux